JBJulia Yoshino Benavente

Julia Yoshino Benavente

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Julia Yoshino Benavente has a total of 109 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clinical validation and machine learning optimization of MyCog: A self‐administered cognitive screener for primary care settings

    by Stephanie Ruth Young, Yusuke Shono, Katherina Hauner, Elizabeth M. Dworak, Maxwell Mansolf, Laura Curtis, Julia Yoshino Benavente, Stephanie Batio, Richard C. Gershon, Michael S. Wolf, et al.

    Background: Primary care offers ideal opportunities for early detection of cognitive impairment, yet clinics face significant barriers to routine screening. MyCog is an electronic health record–integrated tablet application self‐administered during a primary care visit designed to overcome barriers to screening. Methods: We compared MyCog performance between 65 adults age 65+ with diagnosed cognitive impairment and 80 cognitively normal adults. Five modeling approaches achieved consensus to select consistently discriminative variables for the final detection algorithm. Performance was primarily assessed via receiver operating characteristic area under the curve (AUC), sensitivity, specificity, and accuracy. Results: All models demonstrated strong diagnostic performance (AUC 0.817 to 0.873). Memory accuracy and executive function efficiency scores were consistently selected as predictors of impairment across models. The final logistic regression achieved AUC 0.890, with sensitivity 0.723 to 0.831, specificity 0.788 to 0.912, and accuracy 0.807 to 0.828 depending on threshold. Discussion: Findings suggest MyCog accurately detects cognitive impairment via a streamlined self‐administered app that efficiently fits into primary care workflows.


  • Open Access

    MyCog Mobile smartphone-based cognitive screening system: a cross-sectional construct validation in a general population sample at multiple research facilities in the USA

    by Stephanie Ruth Young, Elizabeth McManus Dworak, Greg J Byrne, Callie Madison Jones, Julia Yoshino Benavente, Katherina K Hauner, Richard Gershon, Michael Wolf, Cindy Nowinski

    Objectives Annual cognitive screening in older adults is essential for early detection of cognitive impairment, yet primary care settings face time constraints that present barriers to routine screening. MyCog Mobile is a self-administered, smartphone-based cognitive screener that has the potential to help overcome these screening obstacles. We compared MyCog Mobile to ‘gold-standard’ measures to support its reliability and validity and examined performance differences between in-person versus remote assessment. Design Cross-sectional convenience sample study comparing MyCog Mobile measures to established cognitive assessments. Setting Five in-person research facility locations in Georgia, Texas, New Jersey, Florida and Arizona. Participants 200 adults aged 65–87 years (M=72.56, SD=5.11) who spoke English. Primary outcome measures Convergent and divergent validity were examined via Spearman’s rho correlations between MyCog Mobile measures (MyPictures, MyFaces, MySorting and MySequences) and established measures (verbal paired associates, digit span, letter-number sequencing, Color-Word Interference Test and Trail Making Test), as well as a confirmatory factor analysis using these same measures. Internal consistency was assessed via Spearman-Brown split-half correlations. Score distributions were compared between in-person and remote administration. Results Internal consistency for all MyCog Mobile measures was above acceptable thresholds, ranging from ρ=0.71 to 0.89. Strong correlations were found between MyCog Mobile subtests and their tablet counterparts (MyPictures-Picture Sequence Memory: ρ=0.52; MySorting-dimensional change card sorting: ρ=0.55). MyPictures and MyFaces demonstrated large correlations with convergent memory measures (verbal paired associates immediate ρ=0.51 and 0.56, respectively) and small correlations with discriminant measures. Confirmatory factor analysis supported a two-factor model with subtests loading onto episodic memory and executive functioning factors as expected (χ²(25)=39.136; Comparative Fit Index (CFI) = 0.965; Tucker–Lewis Index (TLI) = 0.950; Root Mean Square Error of Approximation (RMSEA) = 0.053; Standardized Root Mean Square Residual (SRMR) = 0.040). Remote participants scored significantly higher on the MyPictures task overall (t(249)=2.98, p=0.004), while in-person participants scored higher on the MyFaces First Letter subtest and MySequences. Conclusions MyCog Mobile offers a reliable and valid assessment of executive functioning and episodic memory in older adults. Performance may differ by setting, but further research is needed. These findings support future clinical validation studies to determine the diagnostic accuracy of MyCog Mobile to detect cognitive impairment.


  • Open Access

    Hepatic encephalopathy predicts early post-transplant cognitive and functional impairment: The Livcog cohort study

    by Marina Serper, Douglas E. Schaubel, Katheryn A.Q. Cousins, Corey McMillan, Sumeet Asrani, Justin Boike, Julia Yoshino Benavente, Michael S. Wolf


  • Open Access

    Protocol for a construct and clinical validation study of MyCog Mobile: a remote smartphone-based cognitive screener for older adults

    by Stephanie Ruth Young, Elizabeth McManus Dworak, Greg J Byrne, Callie Madison Jones, Julia Yoshino Benavente, Lihua Yao, Laura M Curtis, Maria Varela Diaz, Richard Gershon, Michael Wolf, et al.

    Introduction Annual cognitive screening in older adults is essential for early detection of cognitive impairment, yet primary care settings face time constraints that present barriers to routine screening. A remote cognitive screener completed on a patient’s personal smartphone before a visit has the potential to save primary care clinics time, encourage broader screening practices and increase early detection of cognitive decline. MyCog Mobile is a promising new remote smartphone-based cognitive screening app for primary care settings. We propose a combined construct and clinical validation study of MyCog Mobile. Methods and analysis We will recruit a total sample of 300 adult participants aged 65 years and older. A subsample of 200 healthy adult participants and a subsample of 100 adults with a cognitive impairment diagnosis (ie, dementia, mild cognitive impairment, cognitive deficits or other memory loss) will be recruited from the general population and specialty memory care centres, respectively. To evaluate the construct validity of MyCog Mobile, the healthy control sample will self-administer MyCog Mobile on study-provided smartphones and be administered a battery of gold-standard neuropsychological assessments. We will compare correlations between performance on MyCog Mobile and measures of similar and dissimilar constructs to evaluate convergent and discriminant validity. To assess clinical validity, participants in the clinical sample will self-administer MyCog Mobile on a smartphone and be administered a Mini-Cog screener and these data will be combined with the healthy control sample. We will then apply several supervised model types to determine the best predictors of cognitive impairment within the sample. Area under the receiver operating characteristic curve, accuracy, sensitivity and specificity will be the primary performance metrics for clinical validity. Ethics and dissemination The Institutional Review Board at Northwestern University (STU00214921) approved this study protocol. Results will be published in peer-reviewed journals and summaries provided to the study’s funders.


  • Open Access

    Remote Self-Administration of Cognitive Screeners for Older Adults Prior to a Primary Care Visit: Pilot Cross-Sectional Study of the Reliability and Usability of the MyCog Mobile Screening App

    by Stephanie Ruth Young, Elizabeth McManus Dworak, Greg Joseph Byrne, Callie Madison Jones, Lihua Yao, Julia Noelani Yoshino Benavente, Maria Varela Diaz, Laura Curtis, Richard Gershon, Michael Wolf, et al.

    Background: Routine cognitive screening is essential in the early detection of dementia, but time constraints in primary care settings often limit clinicians’ ability to conduct screenings. MyCog Mobile is a newly developed cognitive screening system that patients can self-administer on their smartphones before a primary care visit, which can help save clinics’ time, encourage broader screening practices, and increase early detection of cognitive decline. Objective: The goal of this pilot study was to examine the feasibility, acceptability, and initial psychometric properties of MyCog Mobile. Research questions included (1) Can older adults complete MyCog Mobile remotely without staff support? (2) Are the internal consistency and test-retest reliability of the measures acceptable? and (3) How do participants rate the user experience of MyCog Mobile? Methods: A sample of adults aged 65 years and older (N=51) self-administered the MyCog Mobile measures remotely on their smartphones twice within a 2- to 3-week interval. The pilot version of MyCog Mobile includes 4 activities: MyFaces measures facial memory, MySorting measures executive functioning, MySequences measures working memory, and MyPictures measures episodic memory. After their first administration, participants also completed a modified version of the Simplified System Usability Scale (S-SUS) and 2 custom survey items. Results: All participants in the sample passed the practice items and completed each measure. Findings indicate that the Mobile Toolbox assessments measure the constructs well (internal consistency 0.73 to 0.91) and are stable over an approximately 2-week delay (test-retest reliability 0.61 to 0.71). Participants’ rating of the user experience (mean S-SUS score 73.17, SD 19.27) indicated that older adults found the usability of MyCog Mobile to be above average. On free-response feedback items, most participants provided positive feedback or no feedback at all, but some indicated a need for clarity in certain task instructions, concerns about participants’ abilities, desire to be able to contact a support person or use in-app technical support, and desire for additional practice items. Conclusions: Pilot evidence suggests that the MyCog Mobile cognitive screener can be reliably self-administered by older adults on their smartphones. Participants in our study generally provided positive feedback about the MyCog Mobile experience and rated the usability of the app highly. Based on participant feedback, we will conduct further usability research to improve support functionality, optimize task instructions and practice opportunities, and ensure that patients feel comfortable using MyCog Mobile. The next steps include a clinical validation study that compares MyCog Mobile to gold-standard assessments and tests the sensitivity and specificity of the measures for identifying dementia.


  • Open Access

    Remote Self-Administration of Cognitive Screeners for Older Adults Prior to a Primary Care Visit: Pilot Cross-Sectional Study of the Reliability and Usability of the MyCog Mobile Screening App (Preprint)

    by Stephanie Ruth Young, Elizabeth McManus Dworak, Greg Joseph Byrne, Callie Madison Jones, Lihua Yao, Julia Noelani Yoshino Benavente, Maria Varela Diaz, Laura Curtis, Richard Gershon, Michael Wolf, et al.

    BACKGROUND Routine cognitive screening is essential in the early detection of dementia, but time constraints in primary care settings often limit clinicians’ ability to conduct screenings. MyCog Mobile is a newly developed cognitive screening system that patients can self-administer on their smartphones before a primary care visit, which can help save clinics’ time, encourage broader screening practices, and increase early detection of cognitive decline. OBJECTIVE The goal of this pilot study was to examine the feasibility, acceptability, and initial psychometric properties of MyCog Mobile. Research questions included (1) Can older adults complete MyCog Mobile remotely without staff support? (2) Are the internal consistency and test-retest reliability of the measures acceptable? and (3) How do participants rate the user experience of MyCog Mobile? METHODS A sample of adults aged 65 years and older (N=51) self-administered the MyCog Mobile measures remotely on their smartphones twice within a 2- to 3-week interval. The pilot version of MyCog Mobile includes 4 activities: MyFaces measures facial memory, MySorting measures executive functioning, MySequences measures working memory, and MyPictures measures episodic memory. After their first administration, participants also completed a modified version of the Simplified System Usability Scale (S-SUS) and 2 custom survey items. RESULTS All participants in the sample passed the practice items and completed each measure. Findings indicate that the Mobile Toolbox assessments measure the constructs well (internal consistency 0.73 to 0.91) and are stable over an approximately 2-week delay (test-retest reliability 0.61 to 0.71). Participants’ rating of the user experience (mean S-SUS score 73.17, SD 19.27) indicated that older adults found the usability of MyCog Mobile to be above average. On free-response feedback items, most participants provided positive feedback or no feedback at all, but some indicated a need for clarity in certain task instructions, concerns about participants’ abilities, desire to be able to contact a support person or use in-app technical support, and desire for additional practice items. CONCLUSIONS Pilot evidence suggests that the MyCog Mobile cognitive screener can be reliably self-administered by older adults on their smartphones. Participants in our study generally provided positive feedback about the MyCog Mobile experience and rated the usability of the app highly. Based on participant feedback, we will conduct further usability research to improve support functionality, optimize task instructions and practice opportunities, and ensure that patients feel comfortable using MyCog Mobile. The next steps include a clinical validation study that compares MyCog Mobile to gold-standard assessments and tests the sensitivity and specificity of the measures for identifying dementia.


  • Open Access

    Long-term impact of the COVID-19 pandemic on self-management of chronic conditions among high-risk adults in the USA: protocol for the C3 observational cohort study

    by Rebecca Lovett, Sarah Filec, Morgan Bonham, Julia Yoshino Benavente, Rachel O'COnor, Andrea Russell, Pauline Zheng, Guisselle Wismer, Esther Yoon, Sophia Weiner-Light, et al.

    Introduction: COVID-19 is an unprecedented public health threat in modern times, especially for older adults or those with chronic illness. Beyond the threat of infection, the pandemic may also have longer-term impacts on mental and physical health. The COVID-19 & Chronic Conditions (‘C3’) study offers a unique opportunity to assess psychosocial and health/healthcare trajectories over 5 years among a diverse cohort of adults with comorbidities well-characterised from before the pandemic, at its onset, through multiple surges, vaccine rollouts and through the gradual easing of restrictions as society slowly returns to ‘normal’. Methods and analysis: The C3 study is an extension of an ongoing longitudinal cohort study of ‘high-risk’ adults (aged 23–88 at baseline) with one or more chronic medical conditions during the COVID-19 pandemic. Five active studies with uniform data collection prior to COVID-19 were leveraged to establish the C3 cohort; 673 adults in Chicago were interviewed during the first week of the outbreak. The C3 cohort has since expanded to include 1044 participants across eight survey waves (T 1 –T 8 ). Four additional survey waves (T 9 –T 12 ) will be conducted via telephone interviews spaced 1 year apart and supplemented by electronic health record and pharmacy fill data, for a total of 5 years of data post pandemic onset. Measurement will include COVID-19-related attitudes/behaviours, mental health, social behaviour, lifestyle/health behaviours, healthcare use, chronic disease self-management and health outcomes. Mental health trajectories and associations with health behaviours/outcomes will be examined in a series of latent group and mixed effects modelling, while also examining mediating and moderating factors. Ethics and dissemination: This study was approved by Northwestern University’s Feinberg School of Medicine Institutional Review Board (STU00215360). Results will be published in international peer-reviewed journals and summaries will be provided to the funders of the study.


  • Open Access

    LitCog Caregiver Cohort: a prospective, observational cohort study investigating US caregivers’ health literacy, self-care skills and cognitive function

    by Rachel O'COnor, Morgan Bonham, Lauren Opsasnick, Grace Magnuson, Julia Yoshino Benavente, Laura M Curtis, Mary Morrissey Kwasny, Michael Wolf

    Introduction Many older adults receive assistance in managing chronic conditions. Yet complicating the utility of caregiver support is whether caregivers have sufficient skills to aid in a patient’s self-care. Health literacy and cognition are important determinants of older adults’ health outcomes, but few studies have examined caregiver health literacy, cognition and self-care skills and their relations to patient outcomes. Methods and analysis We will expand an ongoing cognitive ageing cohort study (LitCog) to enroll a parallel caregiver cohort. Caregivers are eligible if they are (1) ≥18 years of age, (2) provided care for ≥6 months and (3) assisted with at least one activity of daily living, instrumental activity of daily living or health management task. Caregivers will complete interviews at time points corresponding with the LitCog participant interviews. Caregivers will complete assessments of health literacy, self-care skills, cognitive function, caregiver healthcare task difficulty, caregiver burden, caregiver self-efficacy, activation, technology use, busyness and routine and relationship quality. Caregivers will self-report the nature and intensity of care provided, and their own health status. Associations between caregiver presence and caregiver capacity with patient outcomes will be examined in a series of regression models, and mediating and moderating factors will be tested. Ethics and dissemination The Institutional Review Board at Northwestern University has approved the study protocol (STU00026255). Results will be published in peer-reviewed journals and summaries will be provided to the funders of the study as well as patients and caregivers.


  • Open Access

    Primary care detection of cognitive impairment leveraging health and consumer technologies in underserved US communities: protocol for a pragmatic randomised controlled trial of the MyCog paradigm

    by Rebecca Lovett, Morgan Bonham, Julia Yoshino Benavente, Zahra Hosseinian, Greg J Byrne, Maria Varela Diaz, Michael Bass, Lihua Yao, Andrei Adin-Cristian, Stephanie Batio, et al.

    Introduction Early identification of cognitive impairment (CI), including Alzheimer’s disease and related dementias (ADRD), is a top public health priority. Yet, CI/ADRD is often undetected and underdiagnosed within primary care settings, and in health disparate populations. The MyCog paradigm is an iPad-based, self-administered, validated cognitive assessment based on the National Institutes of Health (NIH) Toolbox Cognition Battery and coupled with clinician decision-support tools that is specifically tailored for CI/ADRD detection within diverse, primary care settings. Methods and analysis We will conduct a two-arm, primary care practice-randomised (N=24 practices; 45 257 active patients at the proposed practices), pragmatic trial among geographically diverse Oak Street Health sites to test the effectiveness of the MyCog paradigm to improve early detection CI/ADRD among low socioeconomic, black and Hispanic older adults compared with usual care. Participating practices randomised to the intervention arm will impart the MyCog paradigm as a new standard of care over a 3-year implementation period; as the cognitive component for Annual Wellness Visits and for any patient/informant-reported or healthcare provider-suspected cognitive concern. Rates of detected (cognitive test suggesting impairment) and/or diagnosed (relevant International Classification of Diseases-9/10 [ICD-9/10] code) cognitive deficits, impairments or dementias including ADRD will be our primary outcome of study compared between arms. Secondary outcomes will include ADRD severity (ie, mild or later stage), rates of cognitive-related referrals and rates of family member or caregiver involvement in ADRD care planning. We will use generalised linear mixed models to account for clustered study design. Secondary models will adjust for subject, clinic or visit-specific characteristics. We will use mixed-methods approaches to examine fidelity and cost-effectiveness of the MyCog paradigm. Ethics and dissemination The Institutional Review Board at Advarra has approved the study protocol (Pro00064339). Results will be published in peer-reviewed journals and summaries will be provided to the funders of the study. Trial registration number NCT05607732.


  • Open Access

    Cognitive function, self-management, and outcomes among liver transplant recipients: LivCog, a multicenter, prospective study

    by Marina Serper, Adwait Chafale, Alex Burdzy, Minjee Kim, Sumeet K. Asrani, Julia Yoshino Benavente, Richard Gershon, Peter P. Reese, Douglas E. Schaubel, Justin R. Boike, et al.

    Liver transplantation is a life-saving option for decompensated cirrhosis. Liver transplant recipients require advanced self-management skills, intact cognitive skills, and care partner support to improve long-term outcomes. Gaps remain in understanding post-liver transplant cognitive and health trajectories, and patient factors such as self-management skills, care partner support, and sleep. Our aims are to (1) assess pre-liver transplant to post-liver transplant cognitive trajectories and identify risk factors for persistent cognitive impairment; (2) evaluate associations between cognitive function and self-management skills, health behaviors, functional health status, and post-transplant outcomes; and (3) investigate potential mediators and moderators of associations between cognitive function and post-liver transplant outcomes. LivCog is a longitudinal, prospective observational study that will enroll 450 adult liver transplant recipients and their caregivers/care partners. The duration of the study is 5 years with 24 additional months of patient follow-up. Data will be collected from participants at 1, 3, 12, and 24 months post-transplant. Limited pre-liver transplant data will also be collected from waitlisted candidates. Data collection methods include interviews, surveys, cognitive assessments, and actigraphy/sleep diary measures. Patient measurements include sociodemographic characteristics, pretransplant health status, cognitive function, physical function, perioperative measures, medical history, transplant history, self-management skills, patient-reported outcomes, health behaviors, and clinical outcomes. Caregiver measures assess sociodemographic variables, health literacy, health care navigation skills, self-efficacy, care partner preparedness, nature and intensity of care, care partner burden, and community participation. By elucidating various health trajectories from pre-liver transplant to 2 years post-liver transplant, LivCog will be able to better characterize recipients at higher risk of cognitive impairment and compromised self-management. Findings will inform interventions targeting health behaviors, self-management, and caregiver supports to optimize outcomes.